Treatments : Shots - Health News Here you can find out how the practice of medicine is changing. We pull together the latest research on medical tests, drugs and other therapies.
Shots - Health News

Shots

Health News From NPR

Treatments

Compounded alternatives to Zepbound are on the way out. Guido Mieth/Getty Images/Digital Vision hide caption

toggle caption
Guido Mieth/Getty Images/Digital Vision

Production of cheaper alternatives to name brand obesity drugs will stop on Wednesday

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-5333230/nx-s1-5393663-1" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Long COVID patients haven't stopped pushing for more research funding to find treatments for their condition, including this protest in Washington, D.C. in 2022 which was held in tandem with patients suffering from myalgic encephalomyelitis/chronic fatigue syndrome, or ME/CFS. Anadolu/Anadolu Agency/Getty Images hide caption

toggle caption
Anadolu/Anadolu Agency/Getty Images

Keith Thomas, who lives with paralysis, poses with the research team at Northwell Health's Feinstein Institutes for Medical Research that worked with him for months to restore lasting movement and feeling in his arm and hand. The 'double neural bypass' system uses brain implants and artificial intelligence to allow signals to and from Thomas' brain to bypass the site of his injury. MATTHEW LIBASSI hide caption

toggle caption
MATTHEW LIBASSI

Scientists engineering a sense of touch for people who are paralyzed

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-5313452/nx-s1-5384005-1" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Dr. Jay Bhattacharya, a Stanford University professor, is President Trump's nominee to lead the National Institutes of Health. Taylor Hill/Getty Images hide caption

toggle caption
Taylor Hill/Getty Images

Nominee to run NIH faces Senate scrutiny

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/g-s1-51401/nx-s1-5377098-1" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Myra Solano Garcia in Upland, California, 2024. Garcia has been living with Alzheimer's disease and is taking one of the two approved drugs on the market to try to slow its symptoms. Zaydee Sanchez for NPR / @zaydee.s hide caption

toggle caption
Zaydee Sanchez for NPR / @zaydee.s

Ken and Susan Bell, September, 2024 in St. Charles, Mo. Michael B. Thomas/NPR/@miketphotog hide caption

toggle caption
Michael B. Thomas/NPR/@miketphotog

One woman's experience with the Alzheimer's drug Leqembi

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-5300930/nx-s1-5368688-1" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Ione and Doug Whitney, February, 2025. Megan Farmer, WashU Medicine hide caption

toggle caption
Megan Farmer, WashU Medicine

A man genetically destined to develop Alzheimer's isn't showing any symptoms

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-5293253/nx-s1-5354179-1" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Research participant Doug McCullough uses the adaptive exercise bike during a testing session at the University of Pittsburgh. Nate Langer, UPMC and University of Pittsburgh Health Sciences hide caption

toggle caption
Nate Langer, UPMC and University of Pittsburgh Health Sciences

An experimental spinal treatment may help people with a paralyzing genetic disorder

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-5286644/nx-s1-5349520-1" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Clinical research conducted at the National Institutes of Health campus in Bethesda, Md., continues, but recruitment of new patients is on hold. National Institutes of Health hide caption

toggle caption
National Institutes of Health

Trump's efforts to remake government harming research at the NIH, employees say

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-5286669/nx-s1-5349482-1" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

With funding from the National Science Foundation and other government grants, scientists and meteorologists from the Center for Severe Weather Research study a storm in Oklahoma in 2017. They get close to supercell storms and tornadoes to better understand their formation and improve prediction. Drew Angerer/Getty Images hide caption

toggle caption
Drew Angerer/Getty Images

During William Wilcox's service in the Marines, he fired heavy weapons, including shoulder-mounted missile launchers. The blast waves from those weapons may have led to an arteriovenous malformation (AVM) in his brain. As a result of the malformation and subsequent surgery, he now has epilepsy, memory problems, and other symptoms. Kelly West for NPR/@kwest_photo hide caption

toggle caption
Kelly West for NPR/@kwest_photo

The story of two Marines who developed the same rare brain condition

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-5254359/nx-s1-5305527-1" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Federal regulators have cracked down on mushroom edibles containing Amanita muscaria — also known as fly agaric — after mounting safety concerns. Karl-Josef Hildenbrand/DPA/AFP via Getty Images hide caption

toggle caption
Karl-Josef Hildenbrand/DPA/AFP via Getty Images

FDA targets mushroom edibles following a number of illnesses and suspected deaths

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-5234252/nx-s1-5305748-1" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A surgical team at NYU Langone Health hospital, including Dr. Robert Montgomery (right), transplants a kidney from a genetically modified pig into patient Towana Looney, who's been on dialysis since 2016. Joe Carrotta for NYU Langone Health hide caption

toggle caption
Joe Carrotta for NYU Langone Health

Erica Hayes, 40, sits on her sofa with a box where she keeps the medical supplies she needs to manage her long COVID symptoms, which include chronic fatigue, irregular heart rate, low blood pressure, hives, migraines and internal tremors. Sarah Boden for NPR hide caption

toggle caption
Sarah Boden for NPR

Patients are frustrated that there isn't a reliable treatment yet for long COVID

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-5199994/nx-s1-5298950-1" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

TJ, 35, and Nicole, 41, came to Chimp Haven from the Alamogordo Primate Facility in New Mexico 2018. Another group is expected to arrive from New Mexico in the coming months. Kierstin Luckett/Chimp Haven hide caption

toggle caption
Kierstin Luckett/Chimp Haven

NIH and Chimps

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-5183078/nx-s1-5250767-1" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Dr. Kelsey Leonardsmith (left) with colleague Dylan Flunker in the garden of Family Tree Clinic in Minneapolis. The two run a program to train more doctors and nurses in the region to be able to provide gender affirming care, which is legal in Minnesota, but banned for youth in dozens of states around the country. Selena Simmons-Duffin/NPR hide caption

toggle caption
Selena Simmons-Duffin/NPR